Aphria Inc.

Tilray shareholders vote in favour of Aphria merger, creating the world’s largest cannabis company

Large cannabis companies are starting to experience growth headwinds because of fickle consumers

Cannabis has been legal for almost three years. So why don’t we want to get high off Ottawa’s supply?

Vote by Tilray shareholders on Aphria merger deal delayed until April 30

Aphria shareholders vote in favour of merger, Tilray shareholders set for Friday vote

Tuesday’s upgrades and downgrades: Analysts react to Air Canada deal

Aphria shares plunge 14 per cent days before Tilray merger vote

Aphria reports third-quarter loss, says COVID-19 lockdowns have caused pressure

Proposed Aphria-Tilray merger wins support of two proxy advisory firms

Tilray beats expectations as fourth-quarter loss narrows

Cannabis companies take advantage of stock market rally to raise new financing

Aurora Cannabis received $23.7-million in federal wage-support funding last year while laying off hundreds

Once down in the weeds, cash-strapped pot producers raise billions in market rally

Pot stocks soar again as Tilray, Canopy, Aphria draw retail rush, exasperating Bay Street analysts

The cannabis comeback: Why Aphria’s shares tripled in one month - and the whole sector is booming. Again.

Aphria buzzing about potential for U.S. cannabis legalization under Biden administration

Aphria, Tilray merge with eye on European, U.S. markets

Evening Update: Bellegarde dismayed by O’Toole’s residential school comments; Ottawa signs pact to send Canadian astronaut around the moon

Market movers: Stocks that saw action on Wednesday - and why

Aphria to buy beer maker Sweetwater for $300 million

Cannabis ETFs have crumbled since legalization – is now the time to buy in?

Aphria sales fail to impress Street as COVID-19 pinches drug distribution

Market movers: Stocks that saw action on Wednesday - and why

Cannabis-producer Aphria shares plunge on larger-than-expected loss

Aphria issues shares to Emblem after reaching settlement in supply dispute

Aphria signs $29-million deal to settle dispute with Aleafia and Emblem

Is cannabis still a long-term play worth considering?

Aphria suspends outlook, reports $144.4-million in revenue amid COVID-19

What every Canadian investor needs to know today

Aphria investment raises $100-million from unnamed institutional investor

Aphria signs $100-million deal with unidentified institutional investor

Aphria cuts outlook for 2020, reports second-quarter loss

Aphria cuts 2020 outlook as cannabis company faces setbacks in Ontario, Alberta

Pot-stock interest fizzled in 2019. These charts show how much

How we ranked Canada’s corporate boards

Canadian regulators warn cannabis companies to improve conflict-of-interest disclosures